Potential side effects include anaphylaxis and infusion-related reactions such as rash and diarrhea. Reporting By Mrinalika Roy in Bengaluru; Editing by Shounak DasguptaOur Standards: The Thomson Reuters Trust Principles. It was also shown to stand up against variants first reported in the U.K., South Africa, Brazil, California, New York and India. The therapy, sotrovimab, is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to the virus. Sotrovimab is a monoclonal antibody specifically directed against the spike protein of SARS-CoV-2 that is designed to block the virus attachment and entry into human cells.
Potential side effects include anaphylocus and infusional anaplications.
( z0 include :ARG1 ( z1 and :op ( z2 she ) :op ( z3 ordinal-entity :ARG2 ( z4 idiot ) :op z4 ) ) :ARG1-of ( z5 possible ) :ARG2 ( z6 thing :ARG0-of ( z7 effect ) :mod ( z8 side ) :ord ( z9 ordinal-entity :value "anaphylocus" ) ) )
(z0 / include-01
    :ARG1 (z1 / and
              :op1 (z2 / she)
              :op2 (z3 / ordinal-entity
                       :ARG2 (z4 / idiot)
                       :op1 z4))
    :ARG1-of (z5 / possible-01)
    :ARG2 (z6 / thing
              :ARG0-of (z7 / effect-03)
              :mod (z8 / side)
              :ord (z9 / ordinal-entity
                       :value "anaphylocus")))
Potential side effects include anaphylocus and infusional anaplications .
z6 :mod z8
z6 :ARG0-of z7
z0 :ARG2 z6
z0 :ARG1-of z5
z0 :ARG1 z1
z6 :ord z9
z9 :value 0
z3 :ARG2 z4
z1 :op2 z3
z3 :op1 z4
z1 :op1 z2